About Dr. Peush Bajpai
- Dr. Peush Bajpai is a reputed Medical Oncologist practicing successfully for more than 16 years.
- He offers treatment for Breast Cancer, Gynaecological Cancer, Gastrointestinal Cancer, Prostate and Lung cancer and Hemato-oncology.
- Dr. Bajpai's area of interest covers Molecular Oncology, Precision Oncology, targeted Therapies and Immuno-therapies.
- He is the recipient of numerous awards.
- Dr. Bajpai has participated in different clinical trials as Principal investigator and Co-principal Investigator.
- He has also attended conferences and presented papers in them.
- Dr. Peush Bajpai is a member of the European Society of Medical Oncology (ESMO).
- He has penned articles on Breast Cancer and its prevention.
Hospitals
Specialization
- Osteosarcoma Treatment
- Cancer Screening (Preventive)
- Lung Cancer Treatment
- Tumor Resection & Reconstruction
- Cytology Guided by Ultrasound
- Breast Cancer Management
- Chemotherapy of Solid Tumors
- Chemotherapy of Haematological Malignancies
- Gynaecological Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Molecular Oncology
- Precision Oncology
- Targeted Therapies
- Immuno-therapies
List Of Treatments
- Chemotherapy
- Acute Lymphocytic Leukemia – ALL in Adults
- Breast Biopsy
- Hairy Cell Leukemia – HCL
- Metastatic Tumors Treatment
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Skin Cancer – Melanoma
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Oral Cancer – Surgical
- Breast Cancer
- Leukemia Treatment
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Adenocarcinoma – Glandular Cancer Treatment
- Immunotherapy
- Radiotherapy
- IMRT
- Small Intestine Cancer Treatment
- Bone Marrow Cancer
- Cancer Treatment
- Breast Conservation Surgery – BCS
- Breast Lumpectomy
Work Experience
- Senior Consultant, Medical Oncologist, Max Super Speciality Hospital
- Senior Consultant, BLK Super Speciality Hospital, New Delhi
- Consultant, Manipal Hospitals Dwarka, Delhi
Education
- MBBS, 2003, Gorakhpur University
- MD, 2007, General Medicine, Chhatrapati Shahu Ji Maharaj University, Kanpur
- Specialist Accreditation, Medical Oncology, European Society of Oncology (ESMO) Certificate
- DM, 2012, Oncology, The Tamil Nadu Dr. M.G.R. Medical University, Chennai
Awards
– First prize as a part of a team in a Case presentation at UK Breast Oncoplasty Masterclass-2016
– First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology-2012
– Best poster in BTG Hong Kong “Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances”-2013
